Ysios Capital Overview
Founded in 2008, Ysios Capital is a Spanish venture capital firm specializing in early and development-stage life sciences companies. With over €400 million in assets under management across three dedicated biotech funds, the firm focuses on biotechnology, pharmaceuticals, and medical devices, aiming to address unmet medical needs through innovative therapies and technologies. The team comprises experts with scientific, financial, and legal backgrounds, providing strategic support to portfolio companies in Europe and the United States.
Is Ysios Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Ysios Capital, along with a list of other relevant VCs, is available on Hopohopo.io.
Ysios Capital
Investment focus
Product type
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- PharmaTech
Investment role
Lead and follow
Stages
Series A, Series B or later
First ticket size
€3,000,000 - €20,000,000
Contact information
Chief Financial Officer
Inigo Anitua
Founder & CEO
Joan Bestard
Head of Legal
Wen Cheng
Partner
Guillem Laporta
Partner
Raul Martin-Ruiz
How to approach funds like Ysios Capital
When approaching Ysios Capital, founders should highlight breakthrough science, strong IP positions, and a clear path to clinical validation. Demonstrate a robust understanding of regulatory and reimbursement landscapes, as well as a credible plan for value inflection points. Emphasize the strength and experience of your scientific and management teams, and be prepared to discuss how your solution addresses significant unmet medical needs with global market potential.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
